Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Factors associated with adherence to inhaled medicines in cystic fibrosis following the introduction of elexacaftor/tezacaftor/ivacaftor using electronically captured adherence data.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026

Same author

Genome-wide association study of idiopathic pulmonary fibrosis susceptibility using clinically curated European ancestry datasets.

The European respiratory journal·2026

Same author

Author Correction: Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity.

Nature immunology·2025

Same author

Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity.

Nature immunology·2025

Same author

Sex-specific genetic effects on susceptibility to idiopathic pulmonary fibrosis.

ERJ open research·2025

Same author

Severe lactic acidosis associated with oral linezolid.

Drug and therapeutics bulletin·2025

Search research articles

Related Experiment Video

Updated: May 31, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Idiopathic pulmonary fibrosis.

Zhe Hui Hoo¹, Moira K B Whyte

¹Department of Infection and Immunity, Academic Unit of Respiratory Medicine, University of Sheffield, Sheffield, UK.

|June 24, 2011

Summary

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with no effective treatments. Understanding its molecular mechanisms, particularly alveolar epithelial cell fate and fibrogenesis, is crucial for developing new therapies.

Area of Science:

Pulmonology
Pathophysiology
Molecular Biology

Background:

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis and limited therapeutic options.
Excessive extracellular matrix deposition and recurrent alveolar epithelial injury characterize IPF.
A deeper molecular understanding of these processes is needed to identify therapeutic targets.

Purpose of the Study:

To review recent advances in understanding the pathophysiology of idiopathic pulmonary fibrosis.
To explore the fate of alveolar epithelial cells and mechanisms of fibrogenesis in IPF.
To identify shared mechanistic pathways with co-existing conditions like lung cancer and pulmonary hypertension.

Main Methods:

Review of recent studies published in Thorax and other journals.

Related Experiment Videos

Last Updated: May 31, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Analysis of data from human cells and tissues.

Inclusion of findings from animal models of pulmonary fibrosis.

Main Results:

Recent research has enhanced understanding of IPF pathophysiology at a molecular level.
Key areas of focus include alveolar epithelial cell behavior and fibrogenesis.
Shared mechanistic pathways with lung cancer and pulmonary hypertension have been identified.

Conclusions:

Improved understanding of IPF pathophysiology offers potential for new therapeutic targets.
Further research into molecular mechanisms and biomarkers is essential for managing IPF.
Identifying shared pathways may lead to novel treatment strategies for multiple conditions.